C WorldWide Group Holding A S Sells 933,334 Shares of Outset Medical, Inc. (NASDAQ:OM)

C WorldWide Group Holding A S lowered its stake in shares of Outset Medical, Inc. (NASDAQ:OM - Free Report) by 93.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 66,666 shares of the company's stock after selling 933,334 shares during the period. C WorldWide Group Holding A S owned about 1.85% of Outset Medical worth $737,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of OM. Massachusetts Financial Services Co. MA purchased a new position in Outset Medical in the first quarter valued at about $9,293,000. Squarepoint Ops LLC acquired a new stake in shares of Outset Medical in the 4th quarter valued at $174,000. Two Sigma Investments LP lifted its stake in shares of Outset Medical by 36.0% in the 4th quarter. Two Sigma Investments LP now owns 488,602 shares of the company's stock valued at $542,000 after purchasing an additional 129,334 shares during the last quarter. Birchview Capital LP lifted its stake in shares of Outset Medical by 3,587.7% in the 4th quarter. Birchview Capital LP now owns 368,766 shares of the company's stock valued at $409,000 after purchasing an additional 358,766 shares during the last quarter. Finally, Two Sigma Securities LLC lifted its stake in shares of Outset Medical by 190.0% in the 4th quarter. Two Sigma Securities LLC now owns 42,477 shares of the company's stock valued at $47,000 after purchasing an additional 27,830 shares during the last quarter.

Analysts Set New Price Targets

A number of research firms have weighed in on OM. Scotiabank raised shares of Outset Medical to a "strong-buy" rating in a research report on Thursday, May 15th. Royal Bank Of Canada restated a "sector perform" rating and set a $21.00 target price (up previously from $14.00) on shares of Outset Medical in a research note on Wednesday, May 21st. BTIG Research set a $37.00 target price on Outset Medical and gave the company a "buy" rating in a research note on Monday, July 14th. Finally, Wall Street Zen upgraded Outset Medical from a "sell" rating to a "hold" rating in a research note on Saturday, June 7th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Outset Medical has a consensus rating of "Moderate Buy" and an average target price of $29.50.

Outset Medical Trading Up 3.7%

OM traded up $0.64 during mid-day trading on Monday, reaching $18.06. The stock had a trading volume of 43,023 shares, compared to its average volume of 156,253. The stock has a market capitalization of $320.02 million, a P/E ratio of -0.62 and a beta of 2.15. The company has a debt-to-equity ratio of 0.57, a quick ratio of 6.74 and a current ratio of 8.37. The firm's fifty day simple moving average is $19.29 and its two-hundred day simple moving average is $14.33. Outset Medical, Inc. has a 52 week low of $5.85 and a 52 week high of $62.10.

Outset Medical (NASDAQ:OM - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($3.66) EPS for the quarter, missing analysts' consensus estimates of ($0.97) by ($2.69). Outset Medical had a negative net margin of 98.74% and a negative return on equity of 143.62%. The firm had revenue of $29.75 million during the quarter, compared to the consensus estimate of $27.81 million. On average, equities analysts predict that Outset Medical, Inc. will post -1.99 EPS for the current year.

Outset Medical Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.